BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28076183)

  • 1. Markov Influence Diagrams.
    Díez FJ; Yebra M; Bermejo I; Palacios-Alonso MA; Calleja MA; Luque M; Pérez-Martín J
    Med Decis Making; 2017 Feb; 37(2):183-195. PubMed ID: 28076183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness Analysis with Influence Diagrams.
    Arias M; Díez FJ
    Methods Inf Med; 2015; 54(4):353-8. PubMed ID: 25762363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis with unordered decisions.
    Díez FJ; Luque M; Arias M; Pérez-Martín J
    Artif Intell Med; 2021 Jul; 117():102064. PubMed ID: 34127243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Representation and analysis of medical decision problems with influence diagrams.
    Owens DK; Shachter RD; Nease RF
    Med Decis Making; 1997; 17(3):241-62. PubMed ID: 9219185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decision analysis in radiology using Markov models].
    Golder W
    Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial.
    Williams C; Lewsey JD; Briggs AH; Mackay DF
    Med Decis Making; 2017 May; 37(4):340-352. PubMed ID: 27281337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling.
    Williams C; Lewsey JD; Mackay DF; Briggs AH
    Med Decis Making; 2017 May; 37(4):427-439. PubMed ID: 27698003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic decision modeling in medicine: a critique of existing formalisms.
    Leong TY
    Proc Annu Symp Comput Appl Med Care; 1993; ():478-84. PubMed ID: 8130519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
    Pradelli L; Iannazzo S; Zaniolo O
    Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of influence diagrams to structure medical decisions.
    Nease RF; Owens DK
    Med Decis Making; 1997; 17(3):263-75. PubMed ID: 9219186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to the methods of cost-effectiveness analysis.
    Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete event simulation: the preferred technique for health economic evaluations?
    Caro JJ; Möller J; Getsios D
    Value Health; 2010 Dec; 13(8):1056-60. PubMed ID: 20825626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial.
    Krijkamp EM; Alarid-Escudero F; Enns EA; Jalal HJ; Hunink MGM; Pechlivanoglou P
    Med Decis Making; 2018 Apr; 38(3):400-422. PubMed ID: 29587047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An introduction to the methods of decision-analytic modelling used in economic evaluations for Dermatologists.
    McManus E; Sach TH; Levell NJ
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1829-1836. PubMed ID: 31127965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort decomposition for Markov cost-effectiveness models.
    Hazen G; Li Z
    Med Decis Making; 2011; 31(1):19-34. PubMed ID: 20530723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity Analysis in Sequential Decision Models.
    Chen Q; Ayer T; Chhatwal J
    Med Decis Making; 2017 Feb; 37(2):243-252. PubMed ID: 27681992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.
    Briggs AH; Ades AE; Price MJ
    Med Decis Making; 2003; 23(4):341-50. PubMed ID: 12926584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Probabilistic Markov models in economic evaluation of health technologies: a practical guide].
    Mar J; Antoñanzas F; Pradas R; Arrospide A
    Gac Sanit; 2010; 24(3):209-14. PubMed ID: 20409616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation.
    Karnon J
    Health Econ; 2003 Oct; 12(10):837-48. PubMed ID: 14508868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.